Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/77679
Title: | Indirubin derivative 7-bromoindirubin-3-oxime (7bio) attenuates aβ oligomer-induced cognitive impairments in mice | Authors: | Chen, L Huang, C Shentu, J Wang, M Yan, S Zhou, F Zhang, Z Wang, C Han, Y Wang, Q Cui, W |
Issue Date: | 28-Nov-2017 | Source: | Frontiers in molecular neuroscience, 28 Nov. 2017, v. 10, 393, p. 1-15 | Abstract: | Indirubins are natural occurring alkaloids extracted from indigo dye-containing plants. Indirubins could inhibit various kinases, and might be used to treat chronic myelocytic leukemia, cancer and neurodegenerative disorders. 7-bromoindirubin-3-oxime (7Bio), an indirubin derivative derived from indirubin-3-oxime, possesses inhibitory effects against cyclin-dependent kinase-5 (CDK5) and glycogen synthase kinase-3β (GSK3β), two pharmacological targets of Alzheimer’s disease (AD). In this study, we have discovered that 2.3–23.3 µg/kg 7Bio effectively prevented β-amyloid (Aβ) oligomer-induced impairments of spatial cognition and recognition without affecting bodyweight and motor functions in mice. Moreover, 7Bio potently inhibited Aβ oligomer-induced expression of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). Furthermore, 7Bio significantly prevented the decreased expression of synapsin-1 and PSD-95, biomarkers of pre-synaptic and post-synaptic proteins in Aβ oligomer-treated mice. The mean optical density (OD) with hyper-phosphorylated tau (pTau), glial fibrillary acidic protein (GFAP) and CD45 positive staining in the hippocampus of 7Bio-treated mice were significantly decreased compared to those of Aβ oligomer-treated mice. In addition, Western blotting analysis showed that 7Bio attenuated Aβ oligomer-decreased expression of pSer9-GSK3β. Those results suggested that 7Bio could potently inhibit Aβ oligomer-induced neuroinflammation, synaptic impairments, tau hyper-phosphorylation, and activation of astrocytes and microglia, which may contribute to the neuroprotective effects of 7Bio. Based on these findings, we expected that 7Bio might be developed as a novel anti-AD lead compound. | Publisher: | Frontiers Media SA | Journal: | Frontiers in molecular neuroscience | EISSN: | 1662-5099 | DOI: | 10.3389/fnmol.2017.00393 | Rights: | Copyright © 2017 Chen, Huang, Shentu, Wang, Yan, Zhou, Zhang, Wang, Han, Wang and Cui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. The following publication Chen L, Huang C, Shentu J, Wang M, Yan S, Zhou F, Zhang Z, Wang C, Han Y, Wang Q and Cui W (2017) Indirubin Derivative 7-Bromoindirubin-3-Oxime (7Bio) Attenuates Aβ Oligomer-Induced Cognitive Impairments in Mice. Front. Mol. Neurosci. 10:393,1-15 is available at https://dx.doi.org/10.3389/fnmol.2017.00393 |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Chen_Indirubin_Derivative_7-bromoindirubin-3-oxime.pdf | 4.84 MB | Adobe PDF | View/Open |
Page views
145
Last Week
2
2
Last month
Citations as of Apr 14, 2024
Downloads
84
Citations as of Apr 14, 2024
SCOPUSTM
Citations
17
Last Week
0
0
Last month
Citations as of Apr 19, 2024
WEB OF SCIENCETM
Citations
15
Last Week
0
0
Last month
Citations as of Apr 18, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.